abstract |
A method for preventing loss of bone mass or bone mineral content in a human being suffering from secondary hyperparathyroidism by administering a sufficient amount of 1α-OH vitamin D2, 1α,24(S)-(OH)2 vitamin D2, 1α-OH vitamin D4 or 1α,24(R)-(OH)2 vitamin D4. |